Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium release-activated calcium (CRAC) channels are highly selective plasma membrane ion channels that mediate the influx of Ca(^{2+}) into cells in response to depletion of intracellular calcium stores. They are composed of Orai proteins (Orai1 being the primary pore-forming subunit) and STIM proteins (STIM1 acting as an ER-resident Ca(^{2+}) sensor). Upon store depletion, STIM1 interacts with Orai proteins to open the channel. CRAC channels play a crucial role in immune cell activation, neuronal signaling, and other cellular processes. Dysfunction or mutations in CRAC components can lead to immunodeficiency and other disorders, making them a therapeutic target for immune-related diseases, chronic pain, and possibly cancer.
Modulation of calcium influx through CRAC channels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium Release-Activated Calcium Channel (CRAC).